Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy. - Chao SW; Huang BC; Hong ST; Ho KW; Wang YT; Huang YT; Li CT; Chen SJ; Wang HR; Huang YJ; Hsu YH; Lin WW; et al. (International journal of biological macromolecules, 2026)